2023 - Research.com Immunology in Germany Leader Award
His main research concerns Immunology, Tuberculosis, Mycobacterium tuberculosis, Intensive care medicine and Immune system. His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell and Disease. His studies in Tuberculosis integrate themes in fields like Internal medicine, Clinical trial, Acquired immunodeficiency syndrome, Global health and Drug resistance.
Within one scientific family, he focuses on topics pertaining to Pandemic under Mycobacterium tuberculosis, and may sometimes address concerns connected to Public health. His Intensive care medicine research is multidisciplinary, incorporating perspectives in Bedaquiline, Drug development and Pharmacology. His Immune system research integrates issues from Infectious disease, Interleukin and Infiltration.
Markus Maeurer mainly focuses on Immunology, Immune system, Tuberculosis, Antigen and Mycobacterium tuberculosis. His research investigates the connection with Immunology and areas like Virology which intersect with concerns in Immunoglobulin G. His work carried out in the field of Immune system brings together such families of science as Inflammation, Cancer and Cytokine.
Pharmacology is closely connected to Intensive care medicine in his research, which is encompassed under the umbrella topic of Tuberculosis. His research in Epitope intersects with topics in Molecular biology, Peptide microarray, CTL* and Major histocompatibility complex. His MHC class I research incorporates themes from Antigen presentation and MHC class II.
Markus Maeurer focuses on Immunology, Immune system, Inflammation, Disease and Antibody. His studies deal with areas such as Cancer and Coronavirus as well as Immunology. His Immune system research includes elements of Cytotoxic T cell, Cancer research and Antigen.
His research in the fields of Immunogenicity overlaps with other disciplines such as Gorilla. Markus Maeurer has included themes like Severe acute respiratory syndrome coronavirus 2, Adjuvant, BCG vaccine, Tuberculosis and Innate immune system in his Immunity study. His Tuberculosis research incorporates elements of Drug resistance, Coronavirus disease 2019 and 2019-20 coronavirus outbreak.
Markus Maeurer mainly investigates Immunology, Immune system, Inflammation, Disease and Coronavirus disease 2019. Immunology is closely attributed to Allele in his work. The study incorporates disciplines such as Cytotoxic T cell and Clinical trial in addition to Immune system.
Markus Maeurer has researched Disease in several fields, including Acquired immune system, Serology, Antibody, Asymptomatic and Monocyte. His research in Coronavirus disease 2019 tackles topics such as 2019-20 coronavirus outbreak which are related to areas like Coronavirus Infections, Viral therapy, Betacoronavirus and Intensive care medicine. Markus Maeurer works in the field of Tuberculosis, namely Mycobacterium tuberculosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antigen-processing machinery breakdown and tumor growth.
Barbara Seliger;Markus J Maeurer;Soldano Ferrone.
Immunology Today (2000)
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
Stephen D Lawn;Peter Mwaba;Peter Mwaba;Matthew Bates;Amy Piatek.
Lancet Infectious Diseases (2013)
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
Alimuddin Zumla;Alimuddin Zumla;David S Hui;Esam I Azhar;Ziad A Memish.
The Lancet (2020)
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Alimuddin I Zumla;Alimuddin I Zumla;Stephen H Gillespie;Michael Hoelscher;Patrick P J Philips.
Lancet Infectious Diseases (2014)
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.
Markus J. Maeurer;Susanne M. Gollin;Dina Martin;William Swaney.
Journal of Clinical Investigation (1996)
Single-cell landscape of immunological responses in patients with COVID-19.
Ji Yuan Zhang;Xiang Ming Wang;Xudong Xing;Zhe Xu.
Nature Immunology (2020)
Drug-resistant tuberculosis: time for visionary political leadership
Ibrahim Abubakar;Ibrahim Abubakar;Matteo Zignol;Dennis Falzon;Mario Raviglione.
Lancet Infectious Diseases (2013)
TAP off — tumors on
Barbara Seliger;Barbara Seliger;Markus J. Maeurer;Markus J. Maeurer;Soldano Ferrone;Soldano Ferrone.
Immunology Today (1997)
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts
Ben J Marais;Knut Lönnroth;Stephen D Lawn;Stephen D Lawn;Giovanni Battistai Migliori.
Lancet Infectious Diseases (2013)
Diagnosing Helicobacter pylori in vivo by confocal laser endoscopy.
Ralf Kiesslich;Martin Goetz;Juergen Burg;Manfred Stolte.
Gastroenterology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University College London
National Institutes of Health
Ludwig-Maximilians-Universität München
University of Pittsburgh
University of Pittsburgh
University of Milan
University of Sydney
Karolinska Institute
Queen Mary University of London
University College London
University of Perpignan
Université Paris Cité
Athens University of Economics and Business
Chinese Academy of Sciences
Environment and Climate Change Canada
Virginia Commonwealth University Medical Center
KU Leuven
Cornell University
Southwest Research Institute
Louisiana State University
University of Minnesota
McGill University
Appalachian State University
West Virginia University
Karolinska Institute
National Institutes of Health